Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer

Background: An association between lung cancer and chemokines has been advocated in the recent years. This study aims at investigating the association between lung cancer and 16C/A single nucleotide polymorphism (SNP) (rs. 4359426) in C-C motif chemokine 22 (CCL22) as well as C1014T SNP (rs. 2228428...

Full description

Bibliographic Details
Main Authors: Nasrollah Erfani, Ahmadi-Sina Nedaei Ahmadi, Mohammad Ali Ghayumi, Zahra Mojtahedi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2015-07-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/951
_version_ 1818538424115658752
author Nasrollah Erfani
Ahmadi-Sina Nedaei Ahmadi
Mohammad Ali Ghayumi
Zahra Mojtahedi
author_facet Nasrollah Erfani
Ahmadi-Sina Nedaei Ahmadi
Mohammad Ali Ghayumi
Zahra Mojtahedi
author_sort Nasrollah Erfani
collection DOAJ
description Background: An association between lung cancer and chemokines has been advocated in the recent years. This study aims at investigating the association between lung cancer and 16C/A single nucleotide polymorphism (SNP) (rs. 4359426) in C-C motif chemokine 22 (CCL22) as well as C1014T SNP (rs. 2228428) in C-C chemokine receptor type 4 (CCR4), which serves as the receptor for CCL22. Methods: Genotyping was performed in 148 lung cancer patients and 148 normal controls using Polymerase Chain Reaction-Restriction-Fragment Length Polymorphism (PCR-RFLP). The data were verified by direct automated sequencing. Results: Frequencies of CC, CA and AA genotypes of 16C/A SNP in CCL22 gene were 112 (75.7%), 33 (22.3%) and 3 (2.0%) in patients, and 119 (80.4%), 24 (16.2%) and 5 (3.4%) in controls respectively. No significant differences were observed in genotype frequencies at this position between cases and controls (P=0.34). Moreover, there was no significant association between CCL22 polymorphism and types of lung cancer in patients. The distribution of CC, CT and TT genotypes of C1014T SNP in CCR4 gene, was 76 (51.4%), 60 (40.5%) and 12 (8.1%) in patients, and 80 (54.1%), 49 (33.1%) and 19 (12.8%) in controls respectively. No statistically significant differences were observed in genotypes frequencies of CCR4 gene between patients and controls (P=0.24). The genotype inherited by patients observed not to be associated with the type of lung cancer (P>0.05). Conclusion: Results reveal that CCL22 gene polymorphism at position 16C/A and CCR4 gene polymorphism at position C1014T, appear not to be associated with susceptibility to lung cancer.
first_indexed 2024-12-11T21:28:48Z
format Article
id doaj.art-cd583ede93724bfea397dc05a946ccb8
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-12-11T21:28:48Z
publishDate 2015-07-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-cd583ede93724bfea397dc05a946ccb82022-12-22T00:50:15ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882015-07-01394367373Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung CancerNasrollah Erfani0Ahmadi-Sina Nedaei Ahmadi1Mohammad Ali Ghayumi2Zahra Mojtahedi3Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Department of Internal Medicine, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, IranShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Background: An association between lung cancer and chemokines has been advocated in the recent years. This study aims at investigating the association between lung cancer and 16C/A single nucleotide polymorphism (SNP) (rs. 4359426) in C-C motif chemokine 22 (CCL22) as well as C1014T SNP (rs. 2228428) in C-C chemokine receptor type 4 (CCR4), which serves as the receptor for CCL22. Methods: Genotyping was performed in 148 lung cancer patients and 148 normal controls using Polymerase Chain Reaction-Restriction-Fragment Length Polymorphism (PCR-RFLP). The data were verified by direct automated sequencing. Results: Frequencies of CC, CA and AA genotypes of 16C/A SNP in CCL22 gene were 112 (75.7%), 33 (22.3%) and 3 (2.0%) in patients, and 119 (80.4%), 24 (16.2%) and 5 (3.4%) in controls respectively. No significant differences were observed in genotype frequencies at this position between cases and controls (P=0.34). Moreover, there was no significant association between CCL22 polymorphism and types of lung cancer in patients. The distribution of CC, CT and TT genotypes of C1014T SNP in CCR4 gene, was 76 (51.4%), 60 (40.5%) and 12 (8.1%) in patients, and 80 (54.1%), 49 (33.1%) and 19 (12.8%) in controls respectively. No statistically significant differences were observed in genotypes frequencies of CCR4 gene between patients and controls (P=0.24). The genotype inherited by patients observed not to be associated with the type of lung cancer (P>0.05). Conclusion: Results reveal that CCL22 gene polymorphism at position 16C/A and CCR4 gene polymorphism at position C1014T, appear not to be associated with susceptibility to lung cancer.http://ijms.sums.ac.ir/index.php/IJMS/article/view/951PolymorphismGeneticLung NeoplasmsChemokine CCL22CCR4
spellingShingle Nasrollah Erfani
Ahmadi-Sina Nedaei Ahmadi
Mohammad Ali Ghayumi
Zahra Mojtahedi
Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
Iranian Journal of Medical Sciences
Polymorphism
Genetic
Lung Neoplasms
Chemokine CCL22
CCR4
title Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
title_full Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
title_fullStr Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
title_full_unstemmed Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
title_short Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
title_sort genetic polymorphisms of ccl22 and ccr4 in patients with lung cancer
topic Polymorphism
Genetic
Lung Neoplasms
Chemokine CCL22
CCR4
url http://ijms.sums.ac.ir/index.php/IJMS/article/view/951
work_keys_str_mv AT nasrollaherfani geneticpolymorphismsofccl22andccr4inpatientswithlungcancer
AT ahmadisinanedaeiahmadi geneticpolymorphismsofccl22andccr4inpatientswithlungcancer
AT mohammadalighayumi geneticpolymorphismsofccl22andccr4inpatientswithlungcancer
AT zahramojtahedi geneticpolymorphismsofccl22andccr4inpatientswithlungcancer